Cabtreo

Bausch Health US LLC🇺🇸 United States

FDA Page

Effective Date: Nov 7, 2023
Approval ID: 9468da0f-9978-4c58-8135-0274c3415084
Products: 1 registered
Version: 4

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use CABTREO safely and effectively. See full prescribing information for CABTREO. CABTREO (clindamycin phosphate, adapalene, and benzoyl peroxide) topical gel Initial U.S. Approval: 2023

Quick Stats

Total Products1

Labelers2

Label Sections17

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.